Apr 17, 2019
Global Hodgkin's Lymphoma Drugs Market 2019-2023: Treatment of Hodgkin's Lymphoma Patients with Conjoint Conditions Gaining Momentum
Mar 28, 2019
Seattle Genetics and Astellas Announce Positive Topline Results from Pivotal Trial of Enfortumab Vedotin in Locally Advanced or Metastatic Urothelial Cancer
Mar 19, 2019
Global B-Cell Lymphomas Pipeline Analysis 2019 Featuring Kite Pharma, Celgene, Seattle Genetics, Pfizer, TG Therapeutics, & Sinocelltech
Mar 04, 2019
Biotechnology Companies see Rising Demand for new Therapies
Feb 13, 2019
CytRx Corporation Leads Revival of Cytotoxic Therapies with LADR(TM) Technology Targeting Delivery Directly to the Tumor
Feb 07, 2019
Biotech Companies Introduce New Treatments as Concern Over Cancer Rises
Jan 23, 2019
Antibody Drug Conjugate Market Size Worth USD 9.93 Billion By 2025: Grand View Research, Inc.
Dec 21, 2018
Oxford BioTherapeutics Receives US FDA IND Clearance for OBT076
Dec 21, 2018
CStone Pharmaceuticals announces initiation of CS1001 Phase I Study in U.S., patient enrollment under way
Dec 10, 2018
Oxford BioTherapeutics Expands Strategic Collaboration with WuXi Biologics and Licenses WuXiBody(TM) Platform for Five Bispecific Antibody Programs for up to $450 Million
Dec 03, 2018
News Tips From NYU School Of Medicine And Perlmutter Cancer Center Researchers At The 60th American Society Of Hematology Meeting, Dec. 1-4, In San Diego, Calif.
Nov 28, 2018
Advancing Clinical Trials Endeavoring to Improve Odds Against Pancreatic Cancer
Nov 16, 2018
FDA approves first-line treatment for peripheral T-cell lymphoma under new review pilot
Nov 12, 2018
A Growing Number of Antibody-drug Conjugates (ADCs) are Progressing Through the Clinic and Beyond
Oct 31, 2018
Global Non-Hodgkin Lymphoma Therapeutics Market Outlook to 2025 featuring Novartis, Merck, GSK, Bayer, Pfizer, Celgene, and many more
Oct 26, 2018
Global Non-Hodgkin Lymphoma Market and Competitive Landscape - 2018
Sep 25, 2018
Global Acute Myeloid Leukaemia Market Forecast 2018-2028 - Visiongain Report
Aug 23, 2018
Global Antibody Drug Conjugate Drug Sales, Pipeline Analysis & Market Forecast 2018-2023 - Advances in Linking Technologies Re-Instills Hope in ADC
Jun 21, 2018
Global Antibody Drug Conjugates Market Expected to Reach $3,198 Million by 2023
Jun 03, 2018
Astellas and Seattle Genetics Present at ASCO 2018 on Enfortumab Vedotin in Patients with Locally Advanced or Metastatic Urothelial Cancer Previously Treated with Checkpoint Inhibitor Therapy